| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |